a manifestation of the syndrome, with or without formalized Lake Louise Score assessment.
The likelihood of AMS increases with greater altitude and more rapid ascent. 1 Other risk factors have been considered in a number of epidemiologic investigations, with those analyzed including female sex, younger age, higher body mass index (BMI), and previous episodes of AMS. Findings have also been mixed in regard to some of these, for example, age. 4 Cigarette smoking is another potential risk factor that has been considered in a number of AMS studies. In some of these, smoking-associated risk has been investigated on an a priori basis, driven by suspicion that baseline compromise in oxygen delivery or vascular tone might make AMS more likely. In other studies, smoking status is taken into account as a confounding variable whose potential role is not otherwise specified. The study of cigarette smoking in relation to AMS is further complicated by the heterogeneous attributes of the populations studied. Much of the AMS literature is based on cohorts or case series of mountaineers and other outdoor enthusiasts, among whom prevalence rates and intensity of smoking are relatively low. 5 Other investigations, however, have studied working populations (eg, high altitude miners) or military personnel, among whom patterns of smoking, among other factors, are quite different.
Given such heterogeneity, it is not surprising that the association between smoking and AMS has been inconsistent across studies. Indeed, smoking has variously been found to be strongly protective against AMS or, conversely, a potent risk factor for development of the syndrome. For example, several studies have found that risk of AMS may be 40%-60% lower among smokers, a finding that may be driven by nicotine possibly acting as vasoactive component reducing mild headache intensity or even ablating it completely. Arguing against this proposed mechanism, smoking is known to compromise oxygen delivery and increase vascular tone, two physiologic effects that might make AMS more likely. Hence, the aim of this study was to conduct meta-analysis of available studies of smoking-associated risk for AMS and to do so across a range of populations as well as within more homogenous study subgroups. In so doing, we wished to ascertain whether smoking is or is not a risk factor for AMS and to identify possible sources of heterogeneity in the current literature. Our overall goal is to better inform interventions to reduce the incidence of this common, serious, and potentially preventable syndrome.
Methods

Search Strategy
We used PRISMA protocol for systematic reviews and metaanalyses. 6 Two researchers (DV and CS) did the literature search and data abstraction independently. We searched four databases (Pubmed, Embase, Google Scholar, and Web of Science) for all publications published through April 2015. We used the following search strategies: "smoking" AND "mountain sickness" in Embase; "smoking"[MeSH] AND "altitude sickness"[MeSH Terms] OR altitude sickness[Text Word] in Pubmed; "smoking" AND "acute mountain sickness" in Google Scholar; and "smoking" AND "acute mountain sickness" in the Web of Science. Medical Subject Headings (MeSH) refers to the controlled vocabulary thesaurus used for indexing articles in PubMed. The search algorithm we employed is presented in Figure 1 .
In total, there were 3907 publications identified through these searches. Duplicate citations, animal experimental studies, studies of children, investigations of chronic mountain sickness rather than AMS, conference presentations (eg, abstracts), conference proceedings, and limited case reports were classified as ineligible. From eligible studies, we further identified any additional relevant publications from among the reference citations. The search was carried out in April 2015.
Publications potentially eligible for inclusion (cross-sectional series, retrospective and prospective cohort investigations, and case-control studies) were read by two independent reviewers. Quantitative data on association of smoking and other risk factors with AMS were extracted from each eligible study.
Statistical Analysis
The effect measure in the selected epidemiological studies was the odds ratio (OR). We used the published OR and its associated 95 percent confidence interval (95% CI) or calculated the OR and 95% CI from published data providing the frequencies of smoking and AMS. Some studies provided only a qualitative estimate of the relationship of smoking to AMS without either a numerical estimate of the OR or the percentage of smokers in relation to AMS. In these cases, we contacted the lead author of any otherwise eligible publication and requested the relevant missing data (n = 6 papers included on this basis). Baseline data for each study included were at Boise State University on September 14, 2016 http://ntr.oxfordjournals.org/ Downloaded from the logarithmically transformed OR with its corresponding standard error, which were then input to meta-analysis function of NCSS 9 software (Utah). Percent weights for each study as a contributor to the modeled estimates were calculated based on a weight of each study (W i ), which equaled 1/variance. Hence, studies with greater sample size and smaller standard error, contributor a greater weight to the analysis.
Because of substantial heterogeneity of studies in this analysis, we used a random effects modeling. This model assumes the samples come from populations with different effect sizes such that the true effect may vary substantially across studies. We computed a 95% CI around the mean effect size. Heterogeneity of variance of eligible studies was tested using overall Q value and I 2 values. The Q value is a measure of variance among the effect sizes, and a statistically significant (P < .05) sum of the squares of each effect size about the weighted mean (Q) indicates statistical heterogeneity. A potential problem with the random effects model is that is does not weight by study precision. 7 In order to weight studies on precision, while still incorporating between-study variance, we used the fixed effects model to calculate summary relative risks, then adjusted their 95% CIs for heterogeneity using the method of Shore et al. 8 Publication bias was evaluated using a funnel plot (which shows how many of the published studies had outlier results) and Begg's and Egger's tests that further assess the question of potential publication bias.
9,10
Because we used grouped published data, this analysis was exempt from institutional review for research on human subjects.
Results
In total, we identified 29 papers eligible for analysis. Six publications [11] [12] [13] [14] [15] [16] among this pool of eligible papers did not provide sufficient quantitative data estimates in the initial publication and the authors could not be reached or did not provide such data, although all six concluded that smoking was either not predictive of AMS or that smoking rates did not differ significantly in those with and without AMS. Of the 23 remaining publications, two 5, 17 represented initial reports from cohorts later analyzed and published in expanded form 18, 19 and thus were excluded. Study subject characteristics, altitudes of exposure, and the details of the study designs of the eight excluded papers are summarized in Table 1 . In total, these excluded studies reported on 1859 subjects in four cross-sectional and four prospective cohorts.
Details of the 21 studies ultimately retained in the final analysis, including their ORs and contributory weights, are summarized in Table 2 . These studies included data on 16 566 participants. Four studies were conducted among military personnel (two of these were not explicit on this point, but were from a Chinese military research group), four were occupational, and 13 were in volunteers (one of these studies was mixed, including a minority [14%] of occupationally exposed participants). The publication dates for the studies ranged from 1991 to 2015, with 16 of the 21 appearing in 2006 or thereafter. The top three studies with the greatest contributory weight, Li et al., 29 Bian et al., 32 and MacInnis et al.
33
(together accounting for 46.9% of weight), comprised only 4411 subjects (26.6% of the entire study population). One of these studies showed smoking-associated increased AMS risk, while the other two manifested a protective effect; all, however, were close to an OR = 1.0. The study with the smallest sample size contributed only 45 observations. 36 The smoking-associated ORs ranged from 0.23 to 10.0. When combined, the OR for smoking as predictor for AMS in a random effects model was 0.88 (95% CI = 0.74-1.05). The log transformed OR values for the individual studies and pooled estimate are shown in Figure 2 . The pooled OR from a fixed effect model (Q-value 55.5; P < .001) using a Shore-adjusted 95% CI was similar: OR = 0.90 (95% CI = 0.77-1.06). We further analyzed the 21 included studies This study provided both crude and adjusted estimates for three categories (less than one pack a day; one pack a day and more than one pack a day). Data were combined in two categories: smokers vs. nonsmokers. stratifying them by several different criteria (Table 3) . When stratified into two groups based on cohort types (military/occupational vs. volunteers, trekkers or mixed), the former had a pooled OR = 0.83 (95% CI = 0.58-1.18), while the latter manifested an OR = 0.91 (95% CI = 0.77-1.08). Additional stratification of studies greater than or equal to versus below the median altitude reported (4300 meters above sea level) observed a somewhat greater protective effect at higher compared to lower altitude (pooled OR 0.80 vs. 0.97), although both had wide confidence intervals. Stratified by study design (cross-sectional vs. prospective or case referent) or by location (Asia vs. European/North American) did not reveal substantial differences in the observed pooled risk estimates. No evidence of publication bias was seen in all studies combined in Egger's test (bias coefficient = −0.181; P = .82), Begg's test (P = .74), or in by an inspection of a funnel plot of the results (Figure 3) .
We also conducted sensitivity analysis by sequential exclusion of each study from the overall analysis: the estimated OR did not change substantively following any individual exclusion. The greatest reduction (although not statistically significant) occurred when McDevitt et al. 34 study was excluded (retained pooled OR = 0.85; 95% CI = 0.71-1.01). In contrast, exclusion of the study by You et al. 31 increased the pooled OR to 0.92 (95% CI = 0.78-1.09). When we calculated the pooled OR based on the four studies available that provided the results of multivariate risk modeling including smoking , 25, 35, 36, 38 this was a weakly positive (11% increase) risk factor for AMS with wide confidence intervals (OR = 1.13; 95% CI = 0.53-2.41).
Discussion
In this meta-analysis including data from 21 studies, we did not find definitive evidence that cigarette smoking neither consistently imparted increased risk nor protected against AMS. Thus, although there was a wide range of observed risk estimates, some of which were indeed statistically significant in either direction, this pooled analysis failed to show a pattern from which chance variability could be excluded as the likely explanation. Moreover, subgroup analyses stratified by occupational or military cohorts versus volunteers or avocational status showed a similar pattern of heterogeneous estimates of risk. Limiting the studies to those at the higher versus lower altitude also failed to establish any clear association between cigarette smoking and the risk of AMS in either stratum. Other stratified analyses were similarly nonrevealing. These data, taken together, make it unlikely that smoking is a potent risk factor for AMS, just as smoking is not likely to be strongly protective.
Clearly, delineating risk factors for AMS is critical to adequately inform trekkers and other enthusiasts; assessing fitness for work among occupational and military groups is no less important. Studies of risk factors for AMS have traditionally focused on the attributes of the sojourn itself (rate of ascent, highest altitude reached). Consistent with this, the studies we identified for analysis primarily focused on risk factors other than cigarette smoking. Smoking, when considered at all, typically was included as a potential confounder. Because such studies were not designed to test cigarette smoking as predictive of AMS, exposure ascertainment was not prioritized and typically relied on self-report of dichotomized status (eg, smoker, yes or no) without consideration of intensity (eg, cigarettes smoked per day) or duration.
The marked heterogeneity among the studies included in this meta-analysis likely reflects a variety of factors. Headache is a primary driver of AMS diagnosis. The pathophysiology of headache, in turn, is complex. Vasoconstriction is likely to be a contributor, especially at high altitude. This is relevant to cigarette smoke because nicotine is known to effect the regulation of vascular tone. Mechanistically, cigarette-smoke modulation of vascular tone might explain either increased risk or protection or both, depending on the timing and intensity of exposure. Heterogeneity in smoking-AMS associations could arise from differing cumulative exposure to at Boise State University on September 14, 2016 http://ntr.oxfordjournals.org/ Downloaded from cigarette smoke as a function of smoking intensity, duration, or age in various studies. These are factors that are likely to differ dramatically, for example, between young trekkers that characterize some studies and experienced miners who were the participants in other investigations.
When smoking is an exposure of interest in standard epidemiological or clinical investigations, it typically is verified using biochemical methods, either by measuring cotinine in fluids 39 or quantifying carbon monoxide in exhaled air. Such confirmation is preferred because when self-reported, smoking frequently is underestimated. 40, 41 Moreover, the role of misclassification grows when smoking status shifts from daily smoking to occasional use, 42 a pattern that may be particularly relevant to alpinists and trekkers because of their generally low active smoking prevalence. Given that measuring cotinine can be challenging in field studies as well as costly, exhaled carbon monoxide as a surrogate for exposure should be considered as an alternative. Only two studies in this meta-analysis actually used smoking verification methods, in both cases exhaled carbon monoxide, and both showed positive association of smoking with AMS.
Outcome misclassification was also likely to have been present in many of the studies included in this meta-analysis and this misclassification may have a component of a temporal trend. In earlier studies, Lake Louise Scoring system was not a widely accepted approach to confirm AMS, and even some of the more recent studies we included did not employ this diagnostic tool. Even with scoring, AMS is generally a diagnosis of exclusion, allowing clinicians and even nonmedical personnel in high-altitude sojourns to misinterpret symptoms of other syndromes as a manifestation of AMS. This should be a nondifferential misclassification of disease that would be anticipated to bias toward the null, unless more severe diseases were both less likely to be misclassified and differentially associated with smoking. That association between AMS severity and smoking, however, remains to be disproved. Most of the AMS in the studies included in this meta-analysis appears to be fairly mild, but we did include one nested-case control study of illness severe enough to have been treated with normobaric chamber compression. 36 Of note, that study observed a pronounced, smoking-associated elevated AMS risk. Studies of smoking and high-altitude cerebral edema (HACE), which may represent a more advanced central nervous system response along a spectrum from AMS, as well as investigations of smoking in relation to high-altitude pulmonary edema (HAPE) may shed further light on this risk factor for adverse outcomes following a shared environmental stimulus.
Selection bias is another potential limitation of most of the studies included. Analogous to healthy worker effect in occupational cohorts, studies of volunteers and alpinists will be likely to select physically fit young men, as would studies of military personnel. Subjects in these studies also would be unlikely to have any serious medical conditions or chronic smoking-associated diseases. Our analysis was also limited by having to rely on crude ORs instead of adjusted ORs for most of the studies included. Unmeasured confounders that varied systematically, therefore, also could have contributed to heterogeneity in the observed associations. One candidate confounder might be athleticism, which could be a risk factor for AMS, for example, through over-exertion at altitude, and conversely, negatively associated with cigarette smoking. Finally, most of the studies included were cross-sectional, raising a potential issue of temporality, although this should not be a contributor to the observed heterogeneity in estimated risk.
In summary, this meta-analysis combining studies from around the world, performed at various altitudes and including a variety of participants, did not reveal a consistent and statistically significant association between cigarette smoking and AMS. Given the marked heterogeneity of the available studies, it is not surprising that no convincing pattern emerged of a protective effect or of increased risk of AMS attributable to cigarette smoking. It may only be possible to more definitely address smoking as a possible contributor for AMS through studies focusing on this question and rigorously quantifying both the exposure and outcome.
Funding
None declared.
Declaration of Interests
